159 related articles for article (PubMed ID: 26220638)
1. Quantification of Drug-Induced Inhibition of Canalicular Cholyl-l-Lysyl-Fluorescein Excretion From Hepatocytes by High Content Cell Imaging.
Barber JA; Stahl SH; Summers C; Barrett G; Park BK; Foster JR; Kenna JG
Toxicol Sci; 2015 Nov; 148(1):48-59. PubMed ID: 26220638
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporin A induced internalization of the bile salt export pump in isolated rat hepatocyte couplets.
Román ID; Fernández-Moreno MD; Fueyo JA; Roma MG; Coleman R
Toxicol Sci; 2003 Feb; 71(2):276-81. PubMed ID: 12563113
[TBL] [Abstract][Full Text] [Related]
3. Hepatic transport mechanisms of cholyl-L-lysyl-fluorescein.
de Waart DR; Häusler S; Vlaming ML; Kunne C; Hänggi E; Gruss HJ; Oude Elferink RP; Stieger B
J Pharmacol Exp Ther; 2010 Jul; 334(1):78-86. PubMed ID: 20388726
[TBL] [Abstract][Full Text] [Related]
4. High-Throughput Screening to Evaluate Inhibition of Bile Acid Transporters Using Human Hepatocytes Isolated From Chimeric Mice.
Kohara H; Bajaj P; Yamanaka K; Miyawaki A; Harada K; Miyamoto K; Matsui T; Okai Y; Wagoner M; Shinozawa T
Toxicol Sci; 2020 Feb; 173(2):347-361. PubMed ID: 31722436
[TBL] [Abstract][Full Text] [Related]
5. Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714.
Feng B; Xu JJ; Bi YA; Mireles R; Davidson R; Duignan DB; Campbell S; Kostrubsky VE; Dunn MC; Smith AR; Wang HF
Toxicol Sci; 2009 Apr; 108(2):492-500. PubMed ID: 19223659
[TBL] [Abstract][Full Text] [Related]
6. A Two-Tiered In Vitro Approach to De-Risk Drug Candidates for Potential Bile Salt Export Pump Inhibition Liabilities in Drug Discovery.
Hafey MJ; Houle R; Tanis KQ; Knemeyer I; Shang J; Chen Q; Baudy A; Monroe J; Sistare FD; Evers R
Drug Metab Dispos; 2020 Nov; 48(11):1147-1160. PubMed ID: 32943412
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
Hartman JC; Brouwer K; Mandagere A; Melvin L; Gorczynski R
Can J Physiol Pharmacol; 2010 Jun; 88(6):682-91. PubMed ID: 20628435
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.
Lepist EI; Gillies H; Smith W; Hao J; Hubert C; St Claire RL; Brouwer KR; Ray AS
PLoS One; 2014; 9(1):e87548. PubMed ID: 24498134
[TBL] [Abstract][Full Text] [Related]
9. Different pathways of canalicular secretion of sulfated and non-sulfated fluorescent bile acids: a study in isolated hepatocyte couplets and TR- rats.
Mills CO; Milkiewicz P; Müller M; Roma MG; Havinga R; Coleman R; Kuipers F; Jansen PL; Elias E
J Hepatol; 1999 Oct; 31(4):678-84. PubMed ID: 10551392
[TBL] [Abstract][Full Text] [Related]
10. Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump.
Akita H; Suzuki H; Ito K; Kinoshita S; Sato N; Takikawa H; Sugiyama Y
Biochim Biophys Acta; 2001 Mar; 1511(1):7-16. PubMed ID: 11248200
[TBL] [Abstract][Full Text] [Related]
11. Small hepatocytes in culture develop polarized transporter expression and differentiation.
Sidler Pfändler MA; Höchli M; Inderbitzin D; Meier PJ; Stieger B
J Cell Sci; 2004 Aug; 117(Pt 18):4077-87. PubMed ID: 15280430
[TBL] [Abstract][Full Text] [Related]
12. Phosphoinositide 3-kinase/protein kinase B signaling pathway is involved in estradiol 17β-D-glucuronide-induced cholestasis: complementarity with classical protein kinase C.
Boaglio AC; Zucchetti AE; Sánchez Pozzi EJ; Pellegrino JM; Ochoa JE; Mottino AD; Vore M; Crocenzi FA; Roma MG
Hepatology; 2010 Oct; 52(4):1465-76. PubMed ID: 20815017
[TBL] [Abstract][Full Text] [Related]
13. Quantitative time-lapse imaging-based analysis of drug-drug interaction mediated by hepatobiliary transporter, multidrug resistance-associated protein 2, in sandwich-cultured rat hepatocytes.
Nakanishi T; Shibue Y; Fukuyama Y; Yoshida K; Fukuda H; Shirasaka Y; Tamai I
Drug Metab Dispos; 2011 Jun; 39(6):984-91. PubMed ID: 21415249
[TBL] [Abstract][Full Text] [Related]
14. The Src family kinase Fyn mediates hyperosmolarity-induced Mrp2 and Bsep retrieval from canalicular membrane.
Cantore M; Reinehr R; Sommerfeld A; Becker M; Häussinger D
J Biol Chem; 2011 Dec; 286(52):45014-29. PubMed ID: 22057277
[TBL] [Abstract][Full Text] [Related]
15. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Morgan RE; van Staden CJ; Chen Y; Kalyanaraman N; Kalanzi J; Dunn RT; Afshari CA; Hamadeh HK
Toxicol Sci; 2013 Nov; 136(1):216-41. PubMed ID: 23956101
[TBL] [Abstract][Full Text] [Related]
16. Optimized Hepatocyte-Like Cells with Functional Drug Transporters Directly-Reprogrammed from Mouse Fibroblasts and their Potential in Drug Disposition and Toxicology.
Wu ZT; Yao D; Ji SY; Ni X; Gao YM; Hui LJ; Pan GY
Cell Physiol Biochem; 2016; 38(5):1815-30. PubMed ID: 27160211
[TBL] [Abstract][Full Text] [Related]
17. Biliary excretion in primary rat hepatocytes cultured in a collagen-sandwich configuration.
Liu X; LeCluyse EL; Brouwer KR; Gan LS; Lemasters JJ; Stieger B; Meier PJ; Brouwer KL
Am J Physiol; 1999 Jul; 277(1):G12-21. PubMed ID: 10409146
[TBL] [Abstract][Full Text] [Related]
18. Use of cassette dosing in sandwich-cultured rat and human hepatocytes to identify drugs that inhibit bile acid transport.
Wolf KK; Vora S; Webster LO; Generaux GT; Polli JW; Brouwer KL
Toxicol In Vitro; 2010 Feb; 24(1):297-309. PubMed ID: 19706322
[TBL] [Abstract][Full Text] [Related]
19. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.
Funk C; Ponelle C; Scheuermann G; Pantze M
Mol Pharmacol; 2001 Mar; 59(3):627-35. PubMed ID: 11179459
[TBL] [Abstract][Full Text] [Related]
20. An experimental approach to evaluate the impact of impaired transport function on hepatobiliary drug disposition using Mrp2-deficient TR- rat sandwich-cultured hepatocytes in combination with Bcrp knockdown.
Yang K; Pfeifer ND; Hardwick RN; Yue W; Stewart PW; Brouwer KL
Mol Pharm; 2014 Mar; 11(3):766-75. PubMed ID: 24410402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
